Choate Investment Advisors Astrazeneca PLC Transaction History
Choate Investment Advisors
- $4.53 Billion
- Q3 2025
A detailed history of Choate Investment Advisors transactions in Astrazeneca PLC stock. As of the latest transaction made, Choate Investment Advisors holds 10,308 shares of AZN stock, worth $921,535. This represents 0.02% of its overall portfolio holdings.
Number of Shares
10,308
Previous 10,415
1.03%
Holding current value
$921,535
Previous $727,000
8.67%
% of portfolio
0.02%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,541Shares Held
503MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...